Trial Profile
Amendment of Phase 1 Clinical Trial of the BioMed rTSST-1 Variant Vaccine in Healthy Adults
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jan 2020
Price :
$35
*
At a glance
- Drugs Toxic shock syndrome toxin-1 variant vaccine (Primary)
- Indications Bacterial infections
- Focus Adverse reactions; First in man; Therapeutic Use
- 25 Nov 2016 New trial record